Q1 2025 Financial Results
Bayer recently published its financial results for the first quarter of 2025, which have turned out to be better than expected despite some challenges. This development could potentially have positive effects on stock prices and is of great importance to investors.
- Revenue: Bayer’s revenue in the first quarter of 2025 was 13.738 billion euros, reflecting a decrease of 0.2% compared to the previous year. Adjusted for exchange rate and portfolio effects, revenue fell by 0.1%.
- EBITDA: The EBITDA before special items was 4.085 billion euros, which represents a decline of 7.4% compared to the previous year. The unadjusted EBITDA decreased by 16.8% to 3.498 billion euros.
- Net Income: Net income fell by 35.1% to 1.299 billion euros, corresponding to earnings of 1.32 euros per share, compared to 2.04 euros in the previous year.
- Core Earnings per Share: Core earnings per share amounted to 2.49 euros, reflecting a decrease of 11.7% compared to the previous year.
Outlook and Challenges
- Outlook: Despite the challenges, especially in the Crop Science segment and increased expenses for the long-term incentive program, Bayer considers its targets for 2025 to be achievable. Free cash flow has improved by one billion euros, positively influencing the outlook for the year.
- Pharmaceutical Business: Bayer expects that the pharmaceutical business will fall at the upper end of the forecast, indicating strong performance in this area.
Stock Market and Investors
- Share Price: Bayer’s stock has performed positively in recent days, with an increase of 3.53% to 24.75 euros.
- Market Capitalization: Bayer’s current market capitalization is approximately 23.64 billion euros.
- Dividend Yield: The dividend yield is about 0.57%.
Conclusion
Bayer’s financial results for the first quarter of 2025 have exceeded expectations despite some challenges. The positive development of free cash flow and strong performance in the pharmaceutical business could encourage investors to continue investing in the stock. However, the future price trend will also depend on external factors such as the overall market condition and challenges in the Crop Science segment.